These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35718359)

  • 41. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
    Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
    Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.
    Guo C; Van Damme B; Vanrenterghem Y; Devriendt K; Cassiman JJ; Marynen P
    J Clin Invest; 1995 Apr; 95(4):1832-7. PubMed ID: 7706490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gene analysis and kidney diseases].
    Ishida M
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):463-8. PubMed ID: 8391051
    [No Abstract]   [Full Text] [Related]  

  • 45. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. X-chromosome inactivation: role in skin disease expression.
    Happle R
    Acta Paediatr Suppl; 2006 Apr; 95(451):16-23. PubMed ID: 16720460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alport syndrome, basement membranes and collagen.
    Kashtan CE; Kleppel MM; Butkowski RJ; Michael AF; Fish AJ
    Pediatr Nephrol; 1990 Sep; 4(5):523-32. PubMed ID: 2242324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure.
    Abaci A; Wood K; Demir K; Büyükgebiz A; Böber E; Kopp P
    Endocr Pract; 2010; 16(2):231-6. PubMed ID: 19703807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
    Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
    BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Women and Alport syndrome.
    Rheault MN
    Pediatr Nephrol; 2012 Jan; 27(1):41-6. PubMed ID: 21380623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic renal diseases in children.
    Hildebrandt F
    Curr Opin Pediatr; 1995 Apr; 7(2):182-91. PubMed ID: 7787935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Congenital nephrogenic diabetes insipidus].
    Morin D; Delenne AL; Kervran A
    Arch Pediatr; 2005 Jan; 12(1):59-66. PubMed ID: 15653057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Compound heterozygosis with novel AQP2 gene mutation in sisters affected by autosomal congenital nephrogenic diabetes insipidus].
    Musone D; Nicosia V; Treglia A; Amoroso F; de Gemmis P; Enzo MV; Hladnik U
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Congenital nephrogenic diabetes insipidus: about a case report].
    Esselmani H; Yassine A; Bouabdellah M; Benchekroun L; Handor N; Elalami S; Chabraoui L
    Ann Biol Clin (Paris); 2013; 71(2):241-5. PubMed ID: 23587596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A female patient with Dent disease due to skewed X-chromosome inactivation.
    D'Ambrosio V; Wan ER; Siew K; Hayes W; Walsh SB
    Clin Kidney J; 2024 Jun; 17(6):sfae092. PubMed ID: 38873575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.
    Arthus MF; Lonergan M; Crumley MJ; Naumova AK; Morin D; DE Marco LA; Kaplan BS; Robertson GL; Sasaki S; Morgan K; Bichet DG; Fujiwara TM
    J Am Soc Nephrol; 2000 Jun; 11(6):1044-1054. PubMed ID: 10820168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.